Neobe Therapeutics

London, United Kingdom

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

$2.3M raised

Feb 2024

Seed

Clinical Trials Health Care Medical Therapeutics

Top Investors

Innovate UK 2048 Ventures Deep Science Ventures Cancer Research Horizons Pioneer Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neobe Therapeutics

How much funding has Neobe Therapeutics raised?

Neobe Therapeutics has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in February 2024.

Who are Neobe Therapeutics's investors?

Neobe Therapeutics's investors include Innovate UK, 2048 Ventures, Deep Science Ventures, Cancer Research Horizons, Pioneer Group.

Where is Neobe Therapeutics headquartered?

Neobe Therapeutics is headquartered in London, United Kingdom.

What does Neobe Therapeutics do?

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

What stage is Neobe Therapeutics at?

Neobe Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 29, 2024.

MLA

"Neobe Therapeutics — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/neobe-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Neobe Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neobe-therapeutics

Wikipedia (cite web)

{{cite web |title=Neobe Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neobe-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 29, 2024.

Similar Companies in Clinical Trials